William Dobyns to Imatinib Mesylate
This is a "connection" page, showing publications William Dobyns has written about Imatinib Mesylate.
Connection Strength
0.183
-
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy. Am J Med Genet A. 2020 07; 182(7):1576-1591.
Score: 0.183
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.